Similar Articles
2051 CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: A meta-analysis
2052 Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient
2053 Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations
2054 Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma
2055 Hepatocellular carcinoma treated with transarterial chemoembolization: Dynamic perfusion-CT in the assessment of residual tumor
2056 Leptin in hepatocellular carcinoma
2057 Hepatic blood inflow occlusion without hemihepatic artery control in treatment of hepatocellular carcinoma
2058 Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture
2059 Radiofrequency ablation of hepatocellular carcinoma: Current status
2060 Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA